Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Major depressive disorder (MDD) is a serious mental disorder that represents a substantial public health problem. Several trials have been undertaken to investigate the role of botulinum toxin type A (BTX-A) in the treatment of MDD, but the conclusions were controversial. To examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Huan, Shao, Fangjie, Lenahan, Cameron, Shao, Anwen, Li, Yingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746677/
https://www.ncbi.nlm.nih.gov/pubmed/33343429
http://dx.doi.org/10.3389/fpsyt.2020.603087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746677/
https://www.ncbi.nlm.nih.gov/pubmed/33343429
http://dx.doi.org/10.3389/fpsyt.2020.603087

Ejemplares similares